The Fra-1: Novel Role in Regulating Extensive Immune Cell States and Affecting Inflammatory Diseases

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Aug 29

PMID 36032067

Authors

Yu-Yao He

Hai-Feng Zhou

Lu Chen

Yan-Ting Wang

Wan-Li Xie

Zhen-Zhen Xu

Yue Xiong

Yi-Qi Feng

Guo-Yang Liu

Xia Li

Jie Liu

Qing-Ping Wu

Affiliations

Soon will be listed here.

Abstract

Fra-1(Fos-related antigen1), a member of transcription factor activator protein (AP-1), plays an important role in cell proliferation, apoptosis, differentiation, inflammation, oncogenesis and tumor metastasis. Accumulating evidence suggest that the malignancy and invasive ability of tumors can be significantly changed by directly targeting Fra-1. Besides, the effects of Fra-1 are gradually revealed in immune and inflammatory settings, such as arthritis, pneumonia, psoriasis and cardiovascular disease. These regulatory mechanisms that orchestrate immune and non-immune cells underlie Fra-1 as a potential therapeutic target for a variety of human diseases. In this review, we focus on the current knowledge of Fra-1 in immune system, highlighting its unique importance in regulating tissue homeostasis. In addition, we also discuss the possible critical intervention strategy in diseases, which also outline future research and development avenues.

Citing Articles

Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells.

Zeng F, Cao J, Chen Y, Tang J, He Q, Liao S Cancer Drug Resist. 2024; 7:44.

PMID: 39624082 PMC: 11609144. DOI: 10.20517/cdr.2024.101.

Saikosaponin A Recovers Impaired Filaggrin Levels in Inflamed Skin by Downregulating the Expression of FRA1 and c-Jun.

Ahn S, Yeo H, Jung E, Kim T, Han J, Han Lee Y Molecules. 2024; 29(17).

PMID: 39274912 PMC: 11396542. DOI: 10.3390/molecules29174064.

Blockade of the ADAM8-Fra-1 complex attenuates neuroinflammation by suppressing the Map3k4/MAPKs axis after spinal cord injury.

Qian Z, Li R, Zhao T, Xie K, Li P, Li G Cell Mol Biol Lett. 2024; 29(1):75.

PMID: 38755530 PMC: 11100242. DOI: 10.1186/s11658-024-00589-3.

Epigenetic and transcriptional responses in circulating leukocytes are associated with future decompensation during SARS-CoV-2 infection.

McClain M, Zhbannikov I, Satterwhite L, Henao R, Giroux N, Ding S iScience. 2024; 27(1):108288.

PMID: 38179063 PMC: 10765013. DOI: 10.1016/j.isci.2023.108288.

Identification of potential miR‑155 target genes in epidermal immune microenvironment of atopic dermatitis patients and their inflammatory effects on HaCaT cells.

Wang X, Chen L, Chen X, Liu C, Qiu W, Guo K Exp Ther Med. 2023; 27(1):25.

PMID: 38125354 PMC: 10728954. DOI: 10.3892/etm.2023.12313.

References

Angel P, Karin M . The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991; 1072(2-3):129-57. DOI: 10.1016/0304-419x(91)90011-9. View

Cook S, Aziz N, McMahon M . The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol Cell Biol. 1998; 19(1):330-41. PMC: 83891. DOI: 10.1128/MCB.19.1.330. View

Meisner J, Song J, Price R . Arteriolar and venular remodeling are differentially regulated by bone marrow-derived cell-specific CX3CR1 and CCR2 expression. PLoS One. 2012; 7(9):e46312. PMC: 3454326. DOI: 10.1371/journal.pone.0046312. View

Eferl R, Hasselblatt P, Rath M, Popper H, Zenz R, Komnenovic V . Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc Natl Acad Sci U S A. 2008; 105(30):10525-30. PMC: 2492511. DOI: 10.1073/pnas.0801414105. View

Wang J, Huo K, Ma L, Tang L, Li D, Huang X . Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011; 7:536. PMC: 3261708. DOI: 10.1038/msb.2011.67. View

Young M, Nair R, Bucheimer N, Tulsian P, Brown N, Chapp C . Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol Cell Biol. 2002; 22(2):587-98. PMC: 139745. DOI: 10.1128/MCB.22.2.587-598.2002. View

Ginhoux F, Guilliams M . Tissue-Resident Macrophage Ontogeny and Homeostasis. Immunity. 2016; 44(3):439-449. DOI: 10.1016/j.immuni.2016.02.024. View

Herdegen T, Waetzig V . AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene. 2001; 20(19):2424-37. DOI: 10.1038/sj.onc.1204387. View

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

10.

Wen J, Sun X, Chen H, Liu H, Lai R, Li J . Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish. Brain Res. 2016; 1644:70-8. DOI: 10.1016/j.brainres.2016.04.051. View

11.

Uchihashi S, Fukumoto H, Onoda M, Hayakawa H, Ikushiro S, Sakaki T . Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms. Drug Metab Dispos. 2011; 39(5):803-13. DOI: 10.1124/dmd.110.037952. View

12.

Halazonetis T, Georgopoulos K, Greenberg M, Leder P . c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell. 1988; 55(5):917-24. DOI: 10.1016/0092-8674(88)90147-x. View

13.

Ryseck R, Bravo R . c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene. 1991; 6(4):533-42. View

14.

Huang C, Ma W, Dawson M, Rincon M, Flavell R, Dong Z . Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci U S A. 1997; 94(11):5826-30. PMC: 20865. DOI: 10.1073/pnas.94.11.5826. View

15.

Srivastava M, Saqib U, Naim A, Roy A, Liu D, Bhatnagar D . The TLR4-NOS1-AP1 signaling axis regulates macrophage polarization. Inflamm Res. 2016; 66(4):323-334. DOI: 10.1007/s00011-016-1017-z. View

16.

Zhang M, Hoyle R, Ma Z, Sun B, Cai W, Cai H . FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program. Mol Ther. 2021; 29(8):2583-2600. PMC: 8353207. DOI: 10.1016/j.ymthe.2021.03.024. View

17.

Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B . Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol. 2015; 17(9):1218-27. PMC: 6186417. DOI: 10.1038/ncb3216. View

18.

Hannemann N, Cao S, Eriksson D, Schnelzer A, Jordan J, Eberhardt M . Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis. J Clin Invest. 2019; 129(7):2669-2684. PMC: 6597220. DOI: 10.1172/JCI96832. View

19.

Welter J, Eckert R . Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation. Oncogene. 1995; 11(12):2681-7. View

20.

Phillipson M, Kubes P . The neutrophil in vascular inflammation. Nat Med. 2011; 17(11):1381-90. PMC: 7095830. DOI: 10.1038/nm.2514. View